Zobrazeno 1 - 7
of 7
pro vyhledávání: '"MESH: Alcohol Deterrents"'
Autor:
Benjamin Rolland, Marine Auffret, Baptiste Pignon, Thomas Valin, Sylvie Deheul, Julien Labreuche, Olivier Cottencin, Sophie Gautier, Régis Bordet, Alain Duhamel
Publikováno v:
European Neuropsychopharmacology
European Neuropsychopharmacology, Elsevier, 2015, European neuropsychopharmacology the journal of the European College of Neuropsychopharmacology, 25, pp.1631-1636. ⟨10.1016/j.euroneuro.2015.05.008⟩
European Neuropsychopharmacology, 2015, European neuropsychopharmacology the journal of the European College of Neuropsychopharmacology, 25, pp.1631-1636. ⟨10.1016/j.euroneuro.2015.05.008⟩
European Neuropsychopharmacology, Elsevier, 2015, European neuropsychopharmacology the journal of the European College of Neuropsychopharmacology, 25, pp.1631-1636. ⟨10.1016/j.euroneuro.2015.05.008⟩
European Neuropsychopharmacology, 2015, European neuropsychopharmacology the journal of the European College of Neuropsychopharmacology, 25, pp.1631-1636. ⟨10.1016/j.euroneuro.2015.05.008⟩
International audience; High-dose baclofen, i.e., 300 mg/d or more, has recently emerged as a strategy for treating alcohol dependence. The impact that the co-exposure of large amounts of alcohol and baclofen has on sedation is unclear. In a prospect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::187a0d38561b81dc6adaae0ae63d5e8a
https://hal.univ-lille.fr/hal-02383815
https://hal.univ-lille.fr/hal-02383815
Publikováno v:
Alcoholism: Clinical and Experimental Research
Alcoholism: Clinical and Experimental Research, Wiley, 1998, 22 (4), pp.802-9
Alcoholism: Clinical and Experimental Research, 1998, 22 (4), pp.802-9
Alcoholism: Clinical and Experimental Research, Wiley, 1998, 22 (4), pp.802-9
Alcoholism: Clinical and Experimental Research, 1998, 22 (4), pp.802-9
International audience; It has been suggested that the anticraving drug, acamprosate, acts via the glutamatergic system, but the exact mechanism of action is still unknown. The aim of this study was to characterize [3H]acamprosate binding and establi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf718dab8d58f6c102d8e539ff0bb7ff
https://doi.org/10.1111/j.1530-0277.1998.tb03871.x
https://doi.org/10.1111/j.1530-0277.1998.tb03871.x
Publikováno v:
European Neuropsychopharmacology
European Neuropsychopharmacology, Elsevier, 1997, 7 Suppl 3, pp.S337-40
European Neuropsychopharmacology, Elsevier, 1997, 7 Suppl 3, pp.S337-40
International audience; Alcohol dependence represents a major problem in public health and different animal models of dependence have been developed in rodents with the aim of studying the mechanisms of alcohol abuse. Different ways of animal alcohol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2a6cacef600c56fb2c87cd3b4120476
https://doi.org/10.1016/s0924-977x(97)00066-7
https://doi.org/10.1016/s0924-977x(97)00066-7
Publikováno v:
Addiction Biology
Addiction Biology, Wiley, 2010, 15 (4), pp.424-33. ⟨10.1111/j.1369-1600.2010.00251.x⟩
Addiction Biology, 2010, 15 (4), pp.424-33. ⟨10.1111/j.1369-1600.2010.00251.x⟩
Addiction Biology, Wiley, 2010, 15 (4), pp.424-33. ⟨10.1111/j.1369-1600.2010.00251.x⟩
Addiction Biology, 2010, 15 (4), pp.424-33. ⟨10.1111/j.1369-1600.2010.00251.x⟩
Carnicella S present adress: Grenoble Institut des Neurosciences, Inserm U836; International audience; Ibogaine is a naturally occurring alkaloid that has been reported to decrease various adverse phenotypes associated with exposure to drugs of abuse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1fc498ee0c38ccb35fcffefae22f74b2
https://www.hal.inserm.fr/inserm-00665103/document
https://www.hal.inserm.fr/inserm-00665103/document
Publikováno v:
Neuropharmacology
Neuropharmacology, Elsevier, 2004, 47 (1), pp.35-45. ⟨10.1016/j.neuropharm.2004.03.004⟩
Neuropharmacology, 2004, 47 (1), pp.35-45. ⟨10.1016/j.neuropharm.2004.03.004⟩
Neuropharmacology, Elsevier, 2004, 47 (1), pp.35-45. ⟨10.1016/j.neuropharm.2004.03.004⟩
Neuropharmacology, 2004, 47 (1), pp.35-45. ⟨10.1016/j.neuropharm.2004.03.004⟩
International audience; Acamprosate (calcium acetylhomotaurinate) has been shown to be effective in attenuating relapse in human alcoholics. The precise mechanism for acamprosate has been yet to be determined as there may be multiple sites of action
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82db807503e03db8e1145a4d76eb4522
https://www.hal.inserm.fr/inserm-00746176
https://www.hal.inserm.fr/inserm-00746176
Publikováno v:
Psychopharmacology
Psychopharmacology, Springer Verlag, 1998, 140 (4), pp.421-8
Psychopharmacology, 1998, 140 (4), pp.421-8
Psychopharmacology, Springer Verlag, 1998, 140 (4), pp.421-8
Psychopharmacology, 1998, 140 (4), pp.421-8
International audience; The effect of cyamemazine a dopamine D2 receptor antagonist on voluntary ethanol consumption in rats and on ethanol withdrawal in mice was examined. Male Sprague-Dawley rats were tested in a free choice (water and 10% ethanol)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c479247a6b7f4ee4c28947e4c9e339b7
https://www.hal.inserm.fr/inserm-00746185
https://www.hal.inserm.fr/inserm-00746185
Publikováno v:
Alcohol & Alcoholism; Jan/Feb2010, Vol. 45 Issue 1, p53-63, 11p, 1 Diagram, 5 Charts